SURGIPREP Trademark

Trademark Overview

On Friday, November 4, 2016, a trademark application was filed for SURGIPREP with the United States Patent and Trademark Office. The USPTO has given the SURGIPREP trademark a serial number of 87227133. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 29, 2020. This trademark is owned by Leading BioSciences Inc.. The SURGIPREP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical formulations and preparations for the treatment of acute and chronic health conditions related to viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical formulations and preparations for use in connection with surgical procedures; Biopharmaceutical formulations in liquid form, namely, protease and serine protease inhibitors for the treatment of diseases and disorders; Pharmaceutical formulations and preparations to treat or prevent complications from surgery and post-surgical complications; Pharmaceutical formulations and preparations for treating or preventing shock, namely, acute shock, cardiogenic shock, septic shock and hemorrhagic shock; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal disor...
surgiprep

General Information

Serial Number87227133
Word MarkSURGIPREP
Filing DateFriday, November 4, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 29, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical formulations and preparations for the treatment of acute and chronic health conditions related to viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical formulations and preparations for use in connection with surgical procedures; Biopharmaceutical formulations in liquid form, namely, protease and serine protease inhibitors for the treatment of diseases and disorders; Pharmaceutical formulations and preparations to treat or prevent complications from surgery and post-surgical complications; Pharmaceutical formulations and preparations for treating or preventing shock, namely, acute shock, cardiogenic shock, septic shock and hemorrhagic shock; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal disorders or injuries, ileus and adhesions; Pharmaceutical formulations and preparations to treat or prevent multi-organ failure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 8, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLeading BioSciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSolana Beach, CA 92075
Party NameLeading BioSciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSolana Beach, CA 92075

Trademark Events

Event DateEvent Description
Monday, June 29, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 29, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2019EXTENSION 5 GRANTED
Wednesday, October 23, 2019EXTENSION 5 FILED
Friday, October 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 23, 2019TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 4 GRANTED
Tuesday, April 30, 2019EXTENSION 4 FILED
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 6, 2018EXTENSION 3 GRANTED
Tuesday, November 6, 2018EXTENSION 3 FILED
Tuesday, November 6, 2018TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 2 GRANTED
Monday, May 7, 2018EXTENSION 2 FILED
Monday, May 7, 2018TEAS EXTENSION RECEIVED
Thursday, November 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2017EXTENSION 1 GRANTED
Tuesday, November 7, 2017EXTENSION 1 FILED
Tuesday, November 7, 2017TEAS EXTENSION RECEIVED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 24, 2017ASSIGNED TO LIE
Sunday, January 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 16, 2016NON-FINAL ACTION E-MAILED
Friday, December 16, 2016NON-FINAL ACTION WRITTEN
Friday, December 16, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, December 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Tuesday, November 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

surgiprep formulations pharmaceutical shock preparations treat gastrointestinal surgical protease prevent namely